Marla Shapiro | Academic Influence

Why Is Marla Shapiro Influential?

According to Wikipedia, Marla Shapiro CM, is a Canadian medical doctor, best known as a health journalist for CTV News Channel and formerlyThe Globe and Mail. Her reports on health and medical issues have also aired on Canada AM and on CTV's daytime talk show Balance: Television for Living Well. She is seen regularly on CTV News Channel.

(See a Problem?)

Marla Shapiro's Published Works

Number of citations in a given year to any of this author's works

Total number of citations to an author for the works they published in a given year. This highlights publication of the most important work(s) by the author

Published Works

Nonhormonal management of menopause-associated vasomotor symptoms: 2015 position statement of The North American Menopause Society (2015) (247)
Understanding modern-day vaccines: what you need to know (2018) (177)
Management of genitourinary syndrome of menopause in women with or at high risk for breast cancer: consensus recommendations from The North American Menopause Society and The International Society for the Study of Women's Sexual Health (2018) (111)
Algorithm and mobile app for menopausal symptom management and hormonal/non-hormonal therapy decision making: a clinical decision-support tool from The North American Menopause Society (2015) (61)
Menopause practice A clinician’s guide, 4th edition (2012) (55)
Denosumab, a new pharmacotherapy option for postmenopausal osteoporosis (2013) (39)
Update on herpes zoster vaccination: a family practitioner's guide. (2011) (26)
Is It Time for Vaccination to “Go Viral”? (2016) (15)
Psychosocial Aspects of Siblings' Experiences of Pediatric Cancer. (1994) (13)
Vaccine strategies for prevention of community-acquired pneumonia in Canada: Who would benefit most from pneumococcal immunization? (2019) (12)
NAMS supports judicious use of systemic hormone therapy for women aged 65 years and older. (2015) (11)
Life in the balance: my journey with breast cancer. (2009) (7)
What should guide our patient management of vulvovaginal atrophy? (2018) (6)
An individualized approach to the management of vaginal atrophy in Latin America. (2019) (4)
Efficacy and Safety of Fezolinetant in Moderate-to-Severe Vasomotor Symptoms Associated With Menopause: A Phase 3 RCT. (2023) (4)
Effects of Flibanserin on Subdomain Scores of the Female Sexual Function Index in Women With Hypoactive Sexual Desire Disorder (2022) (4)
Media and education of the consumer. (2016) (4)
Fezolinetant for treatment of moderate-to-severe vasomotor symptoms associated with menopause (SKYLIGHT 1): a phase 3 randomised controlled study (2023) (3)
Faculty Opinions recommendation of Associations of weight gain from early to middle adulthood with major health outcomes later in life. (2017) (1)
Do social determinants of health make a difference in the age at natural menopause in Canada? (2017) (1)
Please don't give hormone therapy a D recommendation or state that "harms far outweigh benefits for prevention of chronic disease". (2017) (1)
CURRICULUM VITAE PERSONAL INFORMATION: Name: (2015) (0)
K-12 Athletic Trainers’ Current Concussion Baseline Practice Patterns (2022) (0)
Gift in barbed wire? (2007) (0)
OR06-5 Fezolinetant for Treatment of Moderate-to-severe Vasomotor Symptoms Associated with Menopause: Results from a 52-week Study (Skylight 2) (2022) (0)
Life in the Balance (2006) (0)
A Master Class in Family Doctor Leadership: Evaluating an Innovative Program. (2021) (0)
Pragmatic studies: their time has come. (2014) (0)
Faculty of 1000 evaluation for Effects of aerobic and resistance exercise on metabolic syndrome, sarcopenic obesity, and circulating biomarkers in overweight or obese survivors of breast cancer: A randomized controlled trial. (2018) (0)
Faculty Opinions recommendation of Genito Pelvic Vaginal Laxity: Classification, Etiology, Symptomatology, and Treatment Considerations. (2018) (0)
Response to Commentary by Spielmans (2022) (0)
Faculty Opinions recommendation of The techno vagina: The laser and radiofrequency device boom in gynecology. (2018) (0)
Fernand Labrie, OC, OQ, MD, PhD, FRCPC, FRSC, CAHS (June 28, 1937–January 16, 2019) (2019) (0)
Faculty Opinions recommendation of Performance of screening ultrasonography as an adjunct to screening mammography in women across the spectrum of breast cancer risk. (2019) (0)
20 The masterclass series in family doctor leadership: evaluation of a new approach to leadership development (2019) (0)
A Phase-3, Randomized, Placebo-Controlled, 12-Week, Double-Blind Study to Assess Efficacy and Safety of Fezolinetant, a Neurokinin-3 Receptor Antagonist, in Women with Moderate-to-Severe Vasomotor Symptoms Associated with Menopause (2022) (0)

This paper list is powered by the following services:

Other Resources About Marla Shapiro

en.wikipedia.org
www.drmarla.ca

What Schools Are Affiliated With Marla Shapiro?

Marla Shapiro is affiliated with the following schools:

McGill University
University of Toronto